We demonstrate that, paradoxically, whereas PLX4032 inhibited extracellular signal-regulated kinase (ERK) in BRAFV600E/K-mutants, it induced the pathway in BRAFWT melanoma cells via activation of RAF1. The gene discussed is RAF1; the disease is melanoma.